CD4 and Alzheimer disease: Together, these studies highlight both distinct methylation changes and correlative gene expressions in the pathogenically relevant CD4+ T cell subset, as well as for Th2 AD maker IL‐13, and the intricacies of multiple epigenetic regulators in AD.